World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
24370
World Ranking
1742
National Ranking
857

Pawel Kalinski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pawel Kalinski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 254 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pawel Kalinski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pawel Kalinski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pawel Kalinski is affiliated with the Roswell Park Comprehensive Cancer Center in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on Oncology and Immunology as main subfields. Additional research interests involve Pulmonary and Respiratory Medicine, Molecular Biology, and Surgery.

The scientist's work covers a broad range of topics related to cancer and immune response, including:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Chemokine receptors and signaling
  • Brain Metastases and Treatment
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Ferroptosis and cancer prognosis

Pawel Kalinski has contributed to numerous publications, with key papers including:

  • "Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer," published in 2022 in Cancer Cell
  • "Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)," published in 2020 in Cancers
  • "Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways," published in 2022 in Molecular Cancer
  • "High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy," published in 2020 in The Prostate
  • "Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma," published in 2021 in Journal for ImmunoTherapy of Cancer

The scientist often collaborates with a select group of frequent co-authors who have contributed to multiple works together, including:

  • Shipra Gandhi
  • Kazuaki Takabe
  • Kristopher Attwood
  • Mateusz Opyrchal
  • Brian J. Czerniecki

The most common venues for Pawel Kalinski's publications are:

  • Cancer Research
  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Cancers
  • Journal for ImmunoTherapy of Cancer

Best Publications

  • Regulation of Immune Responses by Prostaglandin E2

    Pawel Kalinski

  • T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

    Pawel Kaliński;Catharien M.U Hilkens;Eddy A Wierenga;Martien L Kapsenberg

  • Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

    Hideho Okada;Pawel Kalinski;Ryo Ueda;Aki Hoji

  • IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells.

    P. Kalinski;C.M.U. Hilkens;A. Snijders;F.G.M. Snijdewint

  • Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction

    P L Vieira;E C de Jong;E A Wierenga;M L Kapsenberg

  • Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals

    Esther C. de Jong;Pedro L. Vieira;Pawel Kalinski;Joost H. N. Schuitemaker

  • Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes.

    F. G. M. Snijdewint;P. Kalinski;E. A. Wierenga;J. D. Bos

  • α-Type-1 Polarized Dendritic Cells A Novel Immunization Tool with Optimized CTL-inducing Activity

    Robbie B. Mailliard;Anna Wankowicz-Kalinska;Quan Cai;Amy Wesa

  • Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

    Nataša Obermajer;Ravikumar Muthuswamy;Jamie Lesnock;Robert P. Edwards

  • Immunotherapy of Cancer in 2012

    John M. Kirkwood;Lisa H. Butterfield;Ahmad A. Tarhini;Hassane Zarour

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Prostaglandin E2 Induces the Final Maturation of IL-12-Deficient CD1a+CD83+ Dendritic Cells: The Levels of IL-12 Are Determined During the Final Dendritic Cell Maturation and Are Resistant to Further Modulation

    Paweł Kaliński;Joost H. N. Schuitemaker;Catharien M. U. Hilkens;Martien L. Kapsenberg

  • High-level IL-12 production by human dendritic cells requires two signals.

    Alies Snijders;Pawel Kalinski;Catharien M. U. Hilkens;Martien L. Kapsenberg

  • Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer

    Paweł Kaliński;Pedro L. Vieira;Joost H. N. Schuitemaker;Esther C. de Jong

  • PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.

    Nataša Obermajer;Ravikumar Muthuswamy;Kunle O. Odunsi;Robert P. Edwards

  • Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.

    Unknown

  • Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

    Robbie B. Mailliard;Young Ik Son;Richard Redlinger;Patrick T. Coates

  • Human Dendritic Cells Require Exogenous Interleukin-12–Inducing Factors to Direct the Development of Naive T-Helper Cells Toward the Th1 Phenotype

    C.M.U. Hilkens;P. Kalinski;M. de Boer;M.L. Kapsenberg

  • Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells

    Paweł Kaliński;Joost H. N. Schuitemaker;Catharien M. U. Hilkens;Eddy A. Wierenga

  • Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy.

    Zuqiang Liu;Roshni Ravindranathan;Pawel Kalinski;Z. Sheng Guo

  • Th1/Th2 balance in cancer, transplantation and pregnancy.

    Michael R. Shurin;Lina Lu;Pawel Kalinski;Ann M. Stewart-Akers

  • IL-18-induced CD83+CCR7+ NK helper cells.

    Robbie B. Mailliard;Sean M. Alber;Hongmei Shen;Simon C. Watkins

Frequent Co-Authors

Martien L. Kapsenberg
Martien L. Kapsenberg University of Amsterdam
David L. Bartlett
David L. Bartlett University of Pittsburgh
Michael T. Lotze
Michael T. Lotze University of Pittsburgh
John M. Kirkwood
John M. Kirkwood University of Pittsburgh
Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco
Hideho Okada
Hideho Okada University of California, San Francisco
Catharien M. U. Hilkens
Catharien M. U. Hilkens Newcastle University
Herbert J. Zeh
Herbert J. Zeh The University of Texas Southwestern Medical Center
Eddy A. Wierenga
Eddy A. Wierenga University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many aspirants begin with nursing pathways, which provide strong clinical and patient-care foundations. Accelerated programs like absn programs with high acceptance rates offer a faster route into the nursing profession, helping candidates transition quickly while maintaining quality education.

For those seeking a more accessible entry point, lpn programs with easiest admission requirements are an attractive option. Licensed Practical Nurses can support clinical teams and gain valuable experience that complements advanced studies in immunology-related healthcare fields.

Advancing further, many professionals consider becoming Nurse Practitioners. Programs described in what is the easiest np program highlight pathways that balance manageable coursework with accreditation and specialization options, making this transition more accessible.

Specifically, for those interested in mental health allied to immunological conditions, online pmhnp programs with clinical placement provide excellent support and practical experience. These programs ensure students gain hands-on training while benefiting from flexible online learning environments.

Choosing the right degree pathway depends on individual goals and preparedness. Understanding the nuances of program acceptance rates, admission ease, and clinical opportunities helps students align their immunology interests with sustainable and rewarding careers.

Best Scientists Citing Pawel Kalinski

Trending Scientists

Recently Published Articles